S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

SUPN Supernus Pharmaceuticals Inc

39.48

0.00 (0.00%)

Pre Market

Last Updated: 03:14:16

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Supernus Pharmaceuticals (NASDAQ:SUPN)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Supernus Pharmaceuticals Charts.

Supernus Pharmaceuticals (NASDAQ:SUPN)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Supernus Pharmaceuticals Charts.

Supernus Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 February 2025 (13 hours ago) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Wednesday 5 February 2025 (13 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 4 February 2025 (2 days ago) • Edgar (US Regulatory)

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
Tuesday 4 February 2025 (2 days ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 27 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 27 January 2025 (1 week ago) • Edgar (US Regulatory)

Supernus Announces Label Update for Non-Stimulant ADHD Treatment, Qelbree®, Including New Pharmacodynamic Data and Information for Breastfeeding Women
Monday 27 January 2025 (1 week ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 December 2024 (1 month ago) • Edgar (US Regulatory)

More Supernus Pharmaceuticals Inc News Articles

Adia Nutrition (PK)

Decentral Life (PK)

MineralRite (PK)

TransCode Therapeutics

RespireRx Pharmaceuticals (CE)

Virexit Technologies (PK)

Liquidmetal Technologies (QB)

Elite Pharmaceuticals (QB)

Enanta Pharmaceuticals

Rennova Health (CE)

Super Micro Computer

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions